2023 Q3 Form 10-Q Financial Statement

#000149315223024758 Filed on July 17, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2023 Q1
Revenue $2.532K $10.30K $0.00
YoY Change
Cost Of Revenue $7.494K $10.89K
YoY Change -23.56% 1.79%
Gross Profit -$6.077K -$587.00
YoY Change 84.26% -92.33%
Gross Profit Margin -240.01% -5.7%
Selling, General & Admin $280.0K $100.0K $260.0K
YoY Change 2647.79% 160.42% 415.57%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $275.9K $98.45K $260.0K
YoY Change 2606.06% 156.36% 415.67%
Operating Profit -$281.9K -$99.03K
YoY Change 2665.68% 157.89%
Interest Expense -$30.00K $1.699M
YoY Change
% of Operating Profit
Other Income/Expense, Net -$30.44K -$16.05K $0.00
YoY Change -65.15%
Pretax Income -$310.0K -$120.0K -$260.0K
YoY Change 2942.2% 212.5% -85.24%
Income Tax
% Of Pretax Income
Net Earnings -$312.4K -$115.1K -$260.0K
YoY Change 2964.25% 199.69% -85.24%
Net Earnings / Revenue -12336.89% -1117.44%
Basic Earnings Per Share $0.04 -$0.04
Diluted Earnings Per Share $0.04 $0.00 -$0.01
COMMON SHARES
Basic Shares Outstanding 49.19M shares 47.44M shares 10.35M
Diluted Shares Outstanding 48.17M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $410.0K $520.0K $110.0K
YoY Change 177.65% 238.89% -39.15%
Cash & Equivalents $414.1K $517.9K $0.00
Short-Term Investments
Other Short-Term Assets $0.00 $10.00K $550.0K
YoY Change -100.0% -5.48% 1607.54%
Inventory $14.27K $14.27K $6.880K
Prepaid Expenses $2.660K $6.650K $535.00
Receivables $2.500K $2.500K $50.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $433.5K $541.3K $675.3K
YoY Change 185.18% 230.01% 217.09%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.000K $1.000K $1.000K
YoY Change
Total Long-Term Assets $1.000K $1.000K $1.000K
YoY Change 24900.0% -20100.0% 24900.0%
TOTAL ASSETS
Total Short-Term Assets $433.5K $541.3K $675.3K
Total Long-Term Assets $1.000K $1.000K $1.000K
Total Assets $434.5K $542.3K $680.6K
YoY Change 185.83% 230.63% 219.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $50.00K $70.00K $110.0K
YoY Change 4364.29% 2280.95% 716.02%
Accrued Expenses $130.0K $70.00K $20.00K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $120.0K $120.0K $110.0K
YoY Change
Long-Term Debt Due $110.0K $110.0K $110.0K
YoY Change
Total Short-Term Liabilities $403.4K $363.7K $13.44K
YoY Change 35819.59% 12270.71% -0.28%
LONG-TERM LIABILITIES
Long-Term Debt $1.110M $1.150M $1.180M
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $1.110M $1.150M $1.180M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $403.4K $363.7K $13.44K
Total Long-Term Liabilities $1.110M $1.150M $1.180M
Total Liabilities $1.515M $1.509M $13.44K
YoY Change 134824.4% 51223.91% -0.28%
SHAREHOLDERS EQUITY
Retained Earnings -$2.346M -$2.034M -$7.791M
YoY Change -67.6% -71.88% 8.3%
Common Stock $484.8K $474.4K $474.4K
YoY Change 448.07% 436.27% 436.27%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.081M -$966.6K $667.2K
YoY Change
Total Liabilities & Shareholders Equity $434.5K $542.3K $680.6K
YoY Change 185.83% 230.63% 219.59%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income -$312.4K -$115.1K -$260.0K
YoY Change 2964.25% 199.69% -85.24%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$70.00K -$122.0K -$110.0K
YoY Change 1111.07% 346.49% 791.41%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 -$50.00K
YoY Change
Cash From Investing Activities $0.00 -$50.00K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -30.00K -$28.00K 660.0K
YoY Change 439900.0%
NET CHANGE
Cash From Operating Activities -70.00K -$122.0K -110.0K
Cash From Investing Activities 0.000 -50.00K
Cash From Financing Activities -30.00K -$28.00K 660.0K
Net Change In Cash -100.0K -$150.0K 500.0K
YoY Change 1630.1% 449.0% -4201.72%
FREE CASH FLOW
Cash From Operating Activities -$70.00K -$122.0K -$110.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 dei Entity Central Index Key
EntityCentralIndexKey
0000764630
CY2023Q2 dei Amendment Flag
AmendmentFlag
false
CY2023Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--02-29
CY2023Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q2 us-gaap Notes Payable Noncurrent Related Party Type Extensible Enumeration
NotesPayableNoncurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q1 us-gaap Notes Payable Noncurrent Related Party Type Extensible Enumeration
NotesPayableNoncurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q2 SPEV Shares To Be Issued
SharesToBeIssued
usd
CY2023Q1 SPEV Shares To Be Issued
SharesToBeIssued
usd
CY2022Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
usd
CY2022Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
usd
CY2023Q2 SPEV Impairment Of Fixed Asset
ImpairmentOfFixedAsset
usd
CY2022Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
CY2023Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
usd
CY2022Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
CY2022Q2 SPEV Increase Decrease In Accrued Interest Related Party
IncreaseDecreaseInAccruedInterestRelatedParty
usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022Q1 SPEV Funds Held In Escrow
FundsHeldInEscrow
usd
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022Q2 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023Q2 dei Document Type
DocumentType
10-Q
CY2023Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q2 dei Document Period End Date
DocumentPeriodEndDate
2023-05-31
CY2023Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q2 dei Entity File Number
EntityFileNumber
001-15913
CY2023Q2 dei Entity Registrant Name
EntityRegistrantName
SHOREPOWER TECHNOLOGIES INC.
CY2023Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
06-1120072
CY2023Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
5291 NE Elam Young Pkwy
CY2023Q2 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 160
CY2023Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Hillsboro
CY2023Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
OR
CY2023Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
97124
CY2023Q2 dei City Area Code
CityAreaCode
(503)
CY2023Q2 dei Local Phone Number
LocalPhoneNumber
892-7345
CY2023Q2 dei Security12b Title
Security12bTitle
Common Stock
CY2023Q2 dei Trading Symbol
TradingSymbol
SPEV
CY2023Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q2 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q2 dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
49190204 shares
CY2023Q2 us-gaap Cash
Cash
517898 usd
CY2023Q1 us-gaap Cash
Cash
114851 usd
CY2023Q1 us-gaap Escrow Deposit
EscrowDeposit
553000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2500 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
6650 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
535 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
14269 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
6880 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
541317 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
675266 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1000 usd
CY2023Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
1000 usd
CY2023Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
1000 usd
CY2023Q2 us-gaap Assets
Assets
542317 usd
CY2023Q1 us-gaap Assets
Assets
676266 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
69438 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
106394 usd
CY2023Q2 SPEV Accrued Officer Compensation Related Party
AccruedOfficerCompensationRelatedParty
50000 usd
CY2023Q1 SPEV Accrued Officer Compensation Related Party
AccruedOfficerCompensationRelatedParty
20000 usd
CY2023Q2 SPEV Accrued Interest Related Party
AccruedInterestRelatedParty
16092 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
363699 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
343478 usd
CY2023Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
1145224 usd
CY2023Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
1184309 usd
CY2023Q2 us-gaap Liabilities
Liabilities
1508923 usd
CY2023Q1 us-gaap Liabilities
Liabilities
1527787 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
6894356 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
6894356 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
47435106 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47435106 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
47435106 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47435106 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
474351 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
474351 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
615284 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
615284 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2033787 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1918702 usd
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
39975 shares
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
39975 shares
CY2023Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
42454 usd
CY2023Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
42454 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-966606 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-851521 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
542317 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
676266 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10299 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3043 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
10886 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
10695 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
-587 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
-7652 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
14135 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
4656 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
54311 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12032 usd
CY2023Q2 us-gaap Officers Compensation
OfficersCompensation
30000 usd
CY2022Q2 us-gaap Officers Compensation
OfficersCompensation
31200 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
98446 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
47888 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-99033 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-55540 usd
CY2023Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
40 usd
CY2023Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
16092 usd
CY2022Q2 SPEV Impairment Of Fixed Asset
ImpairmentOfFixedAsset
-46063 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-16052 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-46063 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-115085 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-101603 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47435106 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8845348 shares
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-851521 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-115085 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-966606 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-1406086 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-1406086 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-101603 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1507689 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1507689 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-115085 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-101603 usd
CY2022Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
46063 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2500 usd
CY2023Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7389 usd
CY2022Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-9 usd
CY2023Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
6115 usd
CY2022Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
11643 usd
CY2023Q2 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-36956 usd
CY2022Q2 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-61413 usd
CY2023Q2 SPEV Increase Decrease In Accrued Interest Related Party
IncreaseDecreaseInAccruedInterestRelatedParty
16092 usd
CY2023Q2 SPEV Increase Decrease In Accrued Officer Compensation
IncreaseDecreaseInAccruedOfficerCompensation
30000 usd
CY2022Q2 SPEV Increase Decrease In Accrued Officer Compensation
IncreaseDecreaseInAccruedOfficerCompensation
31200 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-121953 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-97387 usd
CY2023Q2 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
28000 usd
CY2022Q2 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
3000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-28000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-149953 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-100387 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
114851 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
319980 usd
CY2023Q1 SPEV Funds Held In Escrow
FundsHeldInEscrow
553000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
517898 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
219593 usd
CY2023Q2 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_849_eus-gaap--UseOfEstimates_zd9ybfZ35Bqk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_861_z61fpqLYZ3Wh">Use of Estimates</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s accounting estimates include the collectability of receivables, useful lives of long-lived assets and recoverability of those assets, impairment in fair value of goodwill.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2 us-gaap Inventory Net
InventoryNet
14269 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
6880 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2033787 usd
CY2023Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
11000000 shares
CY2023Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.06
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
660000 usd
CY2023Q1 us-gaap Legal Fees
LegalFees
553000 usd
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q2 us-gaap Interest Expense
InterestExpense
1699146 usd
CY2023Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
11000000 shares
CY2023Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.06
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
660000 usd
CY2023Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.25
CY2023Q1 us-gaap Class Of Warrant Or Right Expense Or Revenue Recognized
ClassOfWarrantOrRightExpenseOrRevenueRecognized
The warrants are callable by the Company if its common stock trades at $0.75 for at least 20 trading days and at a volume of not less than 30,000 shares per day
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
524737 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01

Files In Submission

Name View Source Status
0001493152-23-024758-index-headers.html Edgar Link pending
0001493152-23-024758-index.html Edgar Link pending
0001493152-23-024758.txt Edgar Link pending
0001493152-23-024758-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
form10-q_htm.xml Edgar Link completed
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
spev-20230531.xsd Edgar Link pending
spev-20230531_def.xml Edgar Link unprocessable
spev-20230531_lab.xml Edgar Link unprocessable
spev-20230531_pre.xml Edgar Link unprocessable
spev-20230531_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable